google s parent company, alphabet, and microsoft have both unveiled quarterly report cards that beat expectations. alphabet shares jumped a little more than 1.5% in after hours trade, as the company announced that its quarterly revenue rose to more than $69 billion. that s 3% higher than the previous year. microsoft stock also got a boost in extended trading, up a smidge over 8.5%, with a quarterly revenue beat that was mainly driven by growth in its cloud computing businesses. of briefings at insider intelligence. some signs of resilience here? yes. although clyde either one or two caveats that. expectations have drops considerably in the last year so this is the type of growth that both of these companies would have been mortified by just a year ago and now expectations have dropped to the point that this is meeting the point that this is meeting the mega expectations of the market is a win. the mega expectations of the market is a win. there is a lot of chat right marke
Carrying electric vehicles rather than coal. the us government pouring trillions and insurance green future is made in the usa with economic consequences for everyone else. fatal islam, bbc news, in kentucky. the european commission is due to publish its pharmaceutical strategy today. it s been reported that the eu is looking at a compulsory licensing system so that in the event of a public health emergency like the pandemic, it would be able to talk control of manufacturing drugs and vaccines. this would go against pharmaceutical groups as they look to protect their patents and could possibly damage relationships between governments and drugmakers. live now to nathalie moll, director general at efpia, european federation of pharmaceutical industries and associations. this is an interesting notion.
We been waiting for a long time but it will also last for the next 20 years, so that really decide what kind of europe will be for the future, a competitive europe with a strong innovation in medical sciences or will we be users or, let s say importers of medical science from the rest of the world with all the risks that pertains because we were the manufacturers and providers of the covid i9 vaccines at the time because we have such a strong life science ecosystem in europe, but might not be the case of the future if the distillation goes away. that s cominu distillation goes away. that s coming uo distillation goes away. that s coming uo very distillation goes away. that s coming up very soon. - distillation goes away. that s. coming up very soon. nathalie moll, director general of the efpia. thank you for your time. this around the world and across the uk. this is bbc news. it is low tide and a good time to get a glimpse of this